Latest News


Reporters and news media writers can visit our page specifically cultivated for press contacts. The page features a list of LUGPA spokespeople.

LUGPAs COVID-19 / Coronavirus Information Hub collects all the relevant resources, announcements and recommended reading about telemedicine, practice management, and events to help you during this pandemic.

LUGPA President Op-Ed: Too Many Black Men Are Dying From Prostate Cancer
Oct. 3, 2021
Prostate-specific antigen (PSA) screening may be more controversial today than decades ago, as more questions have arisen about the balance of benefits versus potential harms of unnecessary treatment. However, there is one aspect of this disease on which the entire healthcare community agrees: for both the diagnosis and treatment of prostate cancer, patient-physician shared decision-making should be optimized. Providers must have the ability to counsel patients on evidence-based best practices, taking into account the individual's risk factors and personal preferences.

HHS Announces $25.5 Billion in Phase 4 Provider Relief Funding  
Sept. 10, 2021

HHS has announced a new round of Provider Relief Finding that will distribute $25.5 billion to eligible providers. Eligibility for Phase 4 payments will be based on providers’ lost revenues and increased expenditures between July 1, 2020 and March 31, 2021. 75% of the Phase 4 allocation will be calculated based on revenue losses and COVID-related expenses and 25% of the Phase 4 allocation will be put towards bonus payments that are based on the amount and type of services provided to Medicaid, CHIP, and Medicare patients. Eligible providers can apply beginning on September 29.

Letter to the Editor from LUGPA President Published in Philadelphia Inquirer   
Aug. 28, 2021

LUGPA President Jonathan Henderson wrote a letter to the editor in response to an article in The Philadelphia Inquirer, "Independent doctors’ offices are disappearing as more physicians work for hospitals and companies."  In Dr. Henderson's letter, he writes about the alarming disappearance of independent physicians as a result of hospital acquisitions. "As a physician representing more than 25% of practicing urologists, I understand these challenges firsthand. Yet the article stopped short of addressing the inherent unfairness in the health care marketplace or the impact on specialty care like urology. Multiple studies suggest prices rise with consolidation, while the quality of care remains stagnant." 

Read the entire letter here

President's Message: The Resilient Spirit of Independent Practices
Aug. 19, 2021

"I have endured dozens of hurricanes, tornados, floods, and one of the higher penetrations of covid, and nothing compares to what we went through in February of this year." Dr. Henderson shares his account of how an ice storm affected his practice... and the whole town of Shreveport, Louisiana.  

LUGPA President: Americans have a right to know costs of hospital care before treatment
Aug. 7, 2021
The Cape Cod Times
recently published a piece about airplanes flying banners over Cape Cod with the phrase, “Prices now a patient's right. Demand them." The article correctly references a 2020 survey regarding price transparency and cites that “more than 90% of Americans support price transparency in healthcare.” As president of the national association that commissioned this poll, I thought your readers would be intrigued by our most recent survey data that found 51% of patients —a higher proportion than ever before — would now prefer to shop for medical tests or services if they had access to pricing information.

CMS Proposes Most Favored Nation Rule Withdrawal
Aug. 9, 2021
LUGPA is pleased to announce that on Friday August 6,CMS issued a Proposed Rule which rescinds the Most Favored Nation Model Interim Final Rule on Part B Drug Pricing (MFN IFR).  That rule, if implemented, would have replaced payment models for essential medications with a flat fee that, in many cases, would have been insufficient to cover the acquisition and administration costs of these drugs.  

Who Will Stand Up for Independent Physicians and Against Hospital Monopolies?
July 19, 2021
LUGPA President, Dr. Jonathan Henderson, writes in Healthcare Business Today:  Across their practices, independent physicians are being buffeted by the unchecked power of hospital monopolies threatening their ability to remain afloat and making the continued practice of medicine increasingly difficult. The growing power of hospitals achieved through system consolidations and the purchase of independent physician practices not only eliminates competition but systematically reduces the quality of care-all while driving costs skyward. LUGPA is poised to address this challenge head-on and work with Secretary Becerra and others to ensure hospital monopolies no longer threaten marketplace fairness and patient access to our services.

MedReviews to Cease Publishing Reviews In Urology
July, 2021
MedReviews has ceased publishing the journal Reviews In Urology (RIU). The final issue was Volume 22, Number 4.  Designated as LUGPA's official journal in 2013, the journal was published quarterly and was indexed and abstracted in PubMed. The website was closed in early October 2021, and all published issues will continue to be available on the PubMed website at or

“LUGPA’s collaboration with Reviews in Urology fulfilled an important role in LUGPA’s overall communications strategy, and provided an outlet for LUGPA members and others to publish their research and scholarly papers.  While we are disappointed that RIU will no longer be published, we look forward to exploring new opportunities to fulfill our mission.” said Dr. David Albala, Associate Editor of RIU

LUGPA Victory: SCOTUS Ruling regarding Site-neutral Payments
June 28, 2021
LUGPA is extremely pleased to inform you that today, the Supreme Court of the United States (SCOTUS) affirmed LUGPA’s position with respect to site-neutral payments for evaluation and management (E/M) services in the hospital outpatient (HOPD) setting. Read more here

US Urology Partners Names Healthcare Visionary Raoul S. Concepcion, MD, as Chief Science Officer
June 27, 2021
Dr. Concepcion will lead scientific operations of the rapidly growing U.S. Urology Partners clinical network, which now includes 24 locations through partners Central Ohio Urology Group and Associated Medical Professionals of NY. Dr. Concepcion’s background includes decades of experience as a pioneer and clinician at the forefront of the industry, including serving as a founding board member and former Past President of LUGPA, the premier nonprofit association and advocate for independent urology practices. Read more here

New Poll Numbers Indicate Growing Concerns Among Americans
About the Impact of Healthcare Consolidation

June 16, 2021
Today, LUGPA released the results of a new national survey of American consumers. Conducted by international polling firm, YouGov, the survey found that patients are concerned about the growing trend of consolidation among healthcare practices and what impacts it will have on costs and access to healthcare services. Read more here

Joint Policy Statement on Most Favored Nation and Foreign Reference Pricing
May 5, 2021
This week, LUGPA signed a joint statement issued to our nation's policymakers regarding our ongoing concerns about the Most Favored Nation (MFN) Model. While its implementation is delayed, Congress has the power to act in a way that protect patient access to urologic care and allow independent physicians to continue providing the highest quality of care. Find our specific recommendations here


Drug pricing too important to be left to narrow regulatory agencies 
April 23, 2021
In a recent article in The Advocate, LUGPA President Dr. Jonathan Henderson writes about the impact of the Most Favored Nation ruling saying, "The rule does not encourage the health care system to use generic medications, does not change the fees Medicare pays large pharmaceutical companies for the drugs, and does not change the structure of Medicare and how it operates. Instead, the rule simply cuts payments to the physicians administering these drugs."  

Medicare Sequester Moratorium Extended
April 14, 2021
LUGPA applauds President Biden and Congress for recognizing the need to extend the Medicare sequester moratorium through the rest of the year by signing H.R. 1868 into law.

CMS instructs Medicare Administrative Contractors to temporarily hold claims
March 30, 2021
Last week, the Senate passed legislation that would extend the moratorium on a 2% Medicare sequester through the public health emergency for COVID-19. Consequently, the House will need to pass the Senate language when it returns from its recess in mid-April. The House is expected to pass the Senate bill; however, CMS has instructed Medicare Administrative Contractors to hold all claims with dates of service on or after April 1, 2021 in anticipation of Congress extending the suspension in order to reduce the number of claims that would need to be reprocessed by MACs.

LUGPA President presents "Tracking Financial Performance to Ensure Physician Practice Stability"
March 29, 2021
In a RevCycle Intelligence webcast, LUGPA President Dr. Jonathan Henderson shared insights on tracking key performance indicators (KPIs) to ensure physician practice stability, a particularly crucial task during the COVID19 crisis. Download the presentation here:

House passes legislation to extend sequester moratorium
March 19, 2021

Today, the House of Representatives passed HR 1868 To prevent across-the-board direct spending cuts, and for other purposes. LUGPA has strongly advocated for extending the moratorium on sequester cuts to Medicare providers, and was a signatory on a letter from a coalition of 43 health care groups to Congressional leaders earlier this month encouraging them to pass legislation to prevent Medicare cuts that threaten the financial viability of physician practices during the public health emergency. Read more.  

Health Policy Roundup
March 16, 2021

Upper tract transitional cell carcinoma: Diagnostic and therapeutic considerations
February 19, 2021, Urology Times
Around the Practice is a monthly urologic virtual tumor board featuring live case review from multidisciplinary experts, presented by Urology Times® in partnership with LUGPA. On January 20, 2021, a panel convened to discuss cases involving an incidentally discovered renal mass as well as upper tract transitional cell carcinoma. What follows is an edited portion of the panel’s conversation regarding the upper tract transitional cell carcinoma case. The panelists included moderator Raoul S. Concepcion, MD, FACS; Jason M. Hafron, MD; Joelle Hamilton, MD; and Jeremy D. Handel, MD.

Impact of Concomitant Prostate Cancer Therapy of Relugolix in Men with Advanced Prostate Cancer
February 22, 2021, UroToday
Daniel George, MD, and Neal Shore, MD, FACS, co-investigators of the Phase III HERO Trial join Alicia Morgans, MD, MPH recapping the 2021 GU ASCO analysis that Dr. Daniel George presented on the efficacy and safety of relugolix vs leuprolide in men with advanced prostate cancer. This was a subgroup analysis assessing the impact of concomitant prostate cancer therapy on the safety and efficacy of the oral GnRH receptor antagonist relugolix versus leuprolide in men with advanced prostate cancer. Relugolix is a first-in-class Federal Drug Administration (FDA) approved, oral, highly selective, GnRH receptor antagonist that is given once daily with an effective half-life of 25 hours.

Health Policy Roundup
Nov-Dec, 2020
As the leading voice of independent urology group practices in the US, LUGPA educates policymakers on the benefits of integrated urologic care. LUGPA's Health Policy and Political Affairs committees drive grassroots efforts by developing thoughtful analysis and engaging public officials through comment letters on major legislative and regulatory proposals. Here's a recap of some of LUGPA's recent activities.  


LUGPA Annual Meeting Recap



Nov. 19, 2020 
Though we couldn’t meet in person this year, our two-day virtual meeting was jam-packed. We exchanged ideas, heard valuable insights, and discussed solutions to enhance, improve, and grow our individual groups. The opportunity for LUGPA members to convene annually was the reason for our foundation and it remains one of the most valuable aspects of our organization. This year’s theme was Facing the Future Together – which is quite timely as we face the challenges ahead amid the COVID-19 pandemic. More than 600 registered for the meeting and approximately 400 attended the event live and on demand so far. We could not have done it without all of your hard work and participation.  
Read the entire recap and see images from the virtual meeting here.  

LUGPA Annual Meeting coverage by Renal & Urology News
Nov. 13, 2020 
Renal & Urology News covered many aspects of LUGPA's 2020 Annual Meeting. Headlines include:

  • Biden Presidency May Affect LUGPA’s Advocacy Efforts
  • Mitomycin Gel for Low-Grade Upper Tract Urothelial Carcinoma
  • Avoiding Litigation by Knowing How to Deal With Angry Patients
  • Alternative Treatments for NMIBC Urged Amid BCG Shortages
  • Private Practices Face Challenges Recruiting Young Urologists

Jonathan Henderson, MD, Elected President of LUGPA Board of Directors
Nov. 7, 2020 
LUGPA, the national voice representing independent urology practices in the U.S., today announced that Jonathan Henderson, MD, was elected to a two-year term as president of LUGPA’s Board of Directors. Dr. Henderson was chosen at LUGPA’s 12th Annual Meeting, which was held virtually on November 6-7. Prior to being elected LUGPA president, Dr. Henderson served as president-elect and secretary, and has been a member of the LUGPA Board of Directors since 2011. 

LUGPA Announces 2020-2021 LUGPA Board of Directors
Nov. 8, 2020 
LUGPA is pleased to announce its 2020-2021 Board of Directors. The newly elected Officers are: Jonathan Henderson, MD, Shreveport, LA, President; Evan Goldfischer, MD, Poughkeepsie, NY, President-Elect; Scott Sellinger, MD, Tallahassee, FL, Secretary; and Dave Carpenter, St. Paul, MN; Treasurer. Newly elected as a member of the LUGPA Board of Directors is Jason Hafron, MD, Troy, MI. Dr. Hafron is a partner and Director of Research at Michigan Institute of Urology. He serves as the Chair of LUGPA Forward and is a member of the LUGPA Program Committee.  

For Physicians, the Next Several Months Are Crucial 
Oct. 30, 2020 
In an op-ed in Morning Consult, Richard G. Harris, MD, president of LUGPA, writes: Throughout a physician’s career, uncertainty is a constant, but it is something we learn to manage using our training, professional expertise and input from colleagues. Yet, the uncertainty experienced by physicians over the last seven months, and the potential disruption we may well see until the public health emergency around COVID-19 ends, will lead to one of the most consequential years in modern medical history.  

Virtual Reality…COVID-style
Oct. 29, 2020 
The latest issue of Reviews in Urology (Volume 22, Number 3) contains Dr. Richard Harris’ final president’s message “Virtual Reality…COVID-style.”   

HHS Announces $20 Billion in Phase 3 Provider Relief Funding - Providers can begin applying for funds October 5, 2020
Oct. 5, 2020 
HHS has announced a new round of Provider Relief Finding that will distribute $20 billion to eligible providers. Eligible providers for this new Phase 3 include providers that have already received Provider Relief Fund payments as well as select groups of providers that were previously ineligible, such as those who began practicing in 2020. 

LUGPA applauds the unanimous passage of Veterans Prostate Cancer Treatment and Research Act
September 24, 2020 
On September 22, 2020, the House of Representatives unanimously passed the Veterans Prostate Cancer Treatment and Research Act (H.R. 6092) supported by LUGPA. The bill, sponsored by Representative Neal Dunn, MD, directs the Secretary of Veterans Affairs to establish a standardized clinical pathway for prostate cancer treatment and submit a plan that provides for continual funding for prostate cancer research through the Veterans Affairs Office of Research and Development. Additionally, the bill creates a real-time registry to track patient progress and will allow patients greater access to cutting edge clinical trials. Read more

How to Save Independent Medical Practices
September 22, 2020 
While independent medical practices face significant challenges, they are an important part of the health care market and need to be protected. In a video interview with Medical Economics, Richard Harris, M.D., president of LUGPA, an organization advocating on behalf of independent physicians, discusses telehealth, the viability and future of independent practice amid the COVID-19 pandemic, hospital consolidation and more.

Dr. Shore Discusses NEJM Studies in Video Series
August 31, 2020 
Neal Shore, MD, FACS, Medical Director for the Carolina Urologic Research Center and Past-President of LUGPA, has led an extensive amount of research in the treatment and management of prostate cancer. In a series of interviews with Oncology Tube, Dr. Shore talks about three recent NEJM Studies (Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer, Olaparib for Metastatic Castration-Resistant Prostate Cancer, and Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer).

Regulators delay final updates to self-referral law
August 27, 2020 
Federal regulators pushed again updates to the self-referral and anti-kickback laws to August 2021, HHS and CMS introduced Wednesday.  “The recent decision to delay final action on the Stark Law and Anti-Kickback Statute is a blow to independent physician practices across the country that see overhaul as necessary to transforming our healthcare system to one that pays for value, said LUGPA president Richard G. Harris, MD. LUGPA and its member practices have been championing the transition from fee-for-service to value-based care models since 2015’s bipartisan passage of MACRA. As a result of this delay, we can expect that the innovation the Administration is so committed to unlocking will remain stymied until CMS finalizes the Anti-Kickback Statute (and Stark) Proposed Rules. It is unclear how yesterday’s announcement will affect the Office of Inspector General’s concurrent process, but our organization will continue to stay engaged so that the nation’s independent physicians have a champion who gives voice to them in their continued fight to expand the services patients want. It’s been proven that independent physicians offer the highest quality care at costs more reasonable than hospitals, letting them expand their offerings without fear of violating anti-kickback statutes will help the entire health care system.” A portion of Dr. Harris quote was used in this article published in Modern Healthcare. 

Optimizing the management of castration‐resistant prostate cancer patients: A practical guide for clinicians
August 15, 2020 
Advanced prostate cancer (PC) patients, especially those with metastatic prostate cancer (mPC), often require complex management pathways. Despite the publication of clinical practice guidelines by leading urological and oncological organizations that provide a substantial and comprehensive framework, there are numerous clinical scenarios that are not always addressed, especially as new treatments become available, new imaging modalities are developed, and advances in genetic testing continue. LUGPA is pleased to announce the publication of this article in The Prostate, by Neal D. Shore, MD, et al. The 14-member expert review panel was comprised of medical oncologists and LUGPA urologists.  

Mathew Fakhoury, DO, Receives LUGPA’s 2020 Resident Clinical Innovation Award
August 13, 2020 
LUGPA announced the selection of Mathew Fakhoury, DO, as winner of the LUGPA 2020 Resident Clinical Innovation Award. In its first year, the Resident Clinical Innovation Award recognizes innovative clinical work of urology residents and fellows that promotes and has the potential to enhance quality clinical outcomes. The award acknowledges the value of clinical innovation to harness new technologies, access big data, develop systems of care to prevent, diagnose or treat urological disease and promote urological health.

New Promising Treatments for Advanced Prostate Cancer
August 5, 2020 
Neal Shore, MD, FACS, Medical Director for the Carolina Urologic Research Center and Past-President of LUGPA, has led an extensive amount of research in the treatment and management of prostate cancer. In an interview with Oncology Times, Shore takes a deeper dive into the research and discusses how we can save the lives of patients living with prostate cancer.

After COVID-19, LUGPA More Important Than Ever
July 31, 2020 
In the Summer 2020 issue of Reviews In Urology, Richard G. Harris, MD, president of LUGPA, writes: In times of crisis like these, LUGPA’s efforts are more important than ever.   

Now Is Price Transparency’s Moment
July 31, 2020 
In an op-ed in Morning Consult, Richard G. Harris, MD, president of LUGPA, writes: “In recent years Americans have become familiar with the quote, “Never let a good crisis go to waste” — and for the nation’s largest hospital systems, many of which are sitting on billions of dollars of financial reserves, the challenges brought on by the coronavirus are no different. Through active lobbying of Congress and the administration, hospitals have received more than $175 billion in bailouts to date with more requested. But, in an effort to flip the script as hospitals lobby for additional funds, Congress should not let this crisis go to waste: now is the time for the federal government to push its price transparency agenda.”

Court Upholds 340B Hospitals Medicare Part B Drug Reimbursement Cuts 
July 31, 2020 
Today, the U.S. Court of Appeals for the District of Columbia Circuit overturned a federal district judge’s ruling that CMS exceeded its statutory authority by reducing Medicare Part B drug reimbursement for 340B hospitals in 2018 and 2019. In today’s ruling, a panel of judges voted 2-1 to affirm CMS’ authority to change OPPS in order to align reimbursement for drugs acquired under the 340B program more closely to hospital costs in acquiring those drugs. 

LUGPA launches After the Storm Webinar Series
July 28, 2020 
LUGPA has launched the After the Storm Webinar Series to address key issues for independent urology practices coming out of the COVID-19 pandemic. The September 2020 webinars will highlight new and emerging treatments in a variety of conditions including prostate cancer, bladder cancer, erectile dysfunction and medical spa services.

LUGPA launches the Executive Leadership Program
July 27, 2020 
LUGPA has launched the Executive Leadership Program, a 12-month comprehensive leadership development course designed specifically for independent urology group physicians and administrators.

Appeals Court Delivers Win for HHS Site-Neutral Payment Policy
Angie Stewart, Becker’s ASC Review 
July 20, 2020 
The U.S. Court of Appeals ruled July 17 that HHS was within its rights to reduce payments to hospital outpatient departments, reversing a district courts earlier decision. Richard Harris, MD, the president of LUGPA, an organization advocating on behalf of independent physicians, shared the following statement on the appellate courts decision: For too long, independent physicians were forced to stand up to the consolidation and market monopolization of large healthcare systems aided by an unfair reimbursement system that paid hospital outpatient departments as much as twice for the same service as independent physicians. With todays decision, the DC Circuit has supported CMS authority to adjust payments under the OPPS system in response to perceived reimbursement dynamics that unnecessarily increase volume of service.

Court Victory for Independent Medicine in Fight for Site-Neutral Payments 
July 17, 2020 
Today, the court has unanimously reversed a district court decision that had determined the rate change in the 2019 OPPS was outside of HHS authority. While the hospital plaintiffs may file an appeal, today’s decision is a big win for independent practices that provide services to Medicare patients to level the playing field.

Independent Practice Perspectives on COVID-19 width=184
July 15, 2020 
At LUGPA, we hear the voices of independent practices across the country and believe you should too. Explore and watch the #IndependentPerspectives of our network of physicians and administrators as they describe on video the impact of COVID-19 on revenue, care delivery and the future of healthcare. Learn more about their experiences and challenges providing care in the midst of a global pandemic.

SRC/NAFC Center of Excellence In Continence Care for Women
July 10, 2020 
Surgical Review Corporation (SRC) and the National Association for Continence (NAFC) have collaborated to create a Center of Excellence in Continence Care for Women (COECCW) accreditation program. Center of Excellence programs recognize hospitals, ambulatory surgical centers and specific medical professionals from their service lines who are committed to achieving defined standards for patient safety and care quality. The COECCW program is focused specifically on facilities that address the needs of those with urinary incontinence, overactive bladder and pelvic organ prolapse. To begin the process of becoming a COECCW or to learn more, click here.

Pandemic Exacts Economic Toll on Urology Practices
June 25, 2020 
COVID-19 caused a huge revenue drop for urology practices nationwide, according to LUGPA President Richard G. Harris, MD, a urologist at UroPartners in the greater Chicago, Illinois, area. “What I’m hearing is most people are functioning with about 30% to 40% capability,” Harris said. Medicine’s revenue cycle tends to lag about 2 months after practices bill for services. Urologists might not have realized the full impact of the COVID-19 monetary crisis until May or into June, according to Harris. Telemedicine is slowly ramping up at UroPartners and should help pay the bills as the practice resumes in-person appointments and elective procedures, according to Harris. “In a normal month, we have between 16,000 and 18,000 evaluation and management code submissions. Right now, the telehealth code submissions are in the 3,000 to 4,000 range. That’s double what it was a month ago,” Harris said in late April. If laws remain relaxed for telehealth use, the trend for increasing utilization will continue in urology. LUGPA is lobbying for the government to keep telehealth regulations as they have been during the pandemic, according to Harris.

Asinof Retires from Urology Center of Colorado and LUGPA Board
June 18, 2020 
At the end of June, Robert D. Asinof, MHSA, retires from his CEO position at the Urology Center of Colorado. He has been the administrator of the group since 1992, and has more than 35 years of experience in the healthcare industry. He will also be retiring from the LUGPA Board at that time.

Practicing Medicine in the COVID-19 Pandemic: Doctors Adapt, Improvise
June 12, 2020 
Our president, Dr. Richard Harris, spoke with Renal & Urology News about the existing and future impact of COVID-19 on his practice. The article contains his insights as well as insights from others in the industry.  

LUGPA Leaders Published in NEJM
June 2, 2020 
LUGPA Past President Neal Shore, MD, and other LUGPA member co-authors had three trials published in the New England Journal of Medicine (NEJM) recently.

  • Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer (PROSPER trial)
  • Olaparib for Metastatic Castration-Resistant Prostate Cancer (PROfound trial)
  • Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer (HERO trial)

More Nuanced Approach Needed to Fight COVID-19

May 29, 2020

In an op-ed in Life Science Leader , John McManus, president and founder of The McManus Groups writes: “As the data on COVID infections and deaths are tabulated, it has become clear that a more nuanced and targeted approach is needed to protect the vulnerable and allow the rest of the country to reopen and get back to work, school, and the day-to-day activities that make life enjoyable. Protecting the elderly, particularly those in nursing homes, should be the paramount public health priority, but continued and indefinite shutdowns of schools, camps, and activities of the young are not relevant to protecting the public.”

Mara R. Holton: Coronavirus Could Shut Down Independent Medical Practices Across Maryland and the Nation
May 24, 2020 
In a Capital Gazette op-ed, LUGPA Board member Mara Holton, MD writes: “What happens to patients and our healthcare system if independent physicians are unable to weather the storm and practices across the nation close? More patients will have no choice but to pay the higher costs seen within local hospital monopolies. Consolidation and care costs will continue increasing unabatedly. Protecting patients and the future of our healthcare system means protecting independent practices. Congress and insurers must step up their support or risk losing this vital part of America’s healthcare infrastructure. The implications of independent practices closing cannot be overstated as we face this crisis and consider the healthcare landscape of the future.”

How COVID-19 Imperiled Physician Practices, And How to Save Them
May 6, 2020 
RevCycle Intelligence has published an article that quotes LUGPA President, Dr. Harris several times and shares his insights and perspectives on the impact of COVID-19 on telehealth, revenue, and reimbursement for independent physicians and their practices.   

Physician groups struggling to survive after COVID-19 — Will they succumb to hospital buyouts? 4 thoughts from Dr. Richard Harris
May 1, 2020 
LUGPA President Richard Harris, MD, a Melrose Park, Ill.-based urology specialist, shared his thoughts with Beckers ASC Review on how independent practices will fare — and what can be done to help them survive — after the crisis subsides.

Can Independent Practices Survive This Crisis Without Government Support? 
April 23, 2020width=164
With in-office visits declining by 50 percent or more, many independent medical practices may need outside help to survive. Medical Economics interviewed LUGPA board member Mara R. Holton, MD, who has been active on the Health Policy and Political Affairs and LUGPA Forward committees.  

From house calls to drive-thru visits, independent physicians adapt amid COVID-19 crisis.
April 14, 2020 
LUGPA President Dr. Harris is quoted in this ABC news article regarding the COVID-19 challenges facing independent physicians. 

American Patients Vastly Prefer Healthcare Price Transparency, According to New Survey

April 3, 2020 
Medical Economics
 published an article on LUGPAs price transparency survey. The article shares the findings from the survey, and includes quotes from LUGPA President Dr. Harris. Additionally, the same article also appeared in Physicians Practice.  

New Survey Finds 91% of Americans Want Healthcare Price Transparency
April 1, 2020
LUGPA released the results of a new survey of American consumers that found an overwhelming majority of Americans support price transparency in healthcare. When surveyed, 91% of the 1,342 respondents said they believe hospitals and healthcare facilities should be required to publicly disclose the costs of their services. What’s more, 66% of respondents believe price transparency will improve healthcare.

LUGPA Leaders Convene Panel to Optimize Role of ADT in Advanced Prostate Cancer
March 23, 2020
LUGPA is pleased to announce the publication of Optimizing the Role of Androgen Deprivation Therapy in Advanced Prostate Cancer: Challenges Beyond the Guidelines in The Prostate (Prostate. 2020 Mar 4. doi: 10.1002/pros.23967),  Neal D. Shore, MD, et al.  Dr. Shore, Past President of LUGPA (2016-2018), led a 14- member expert panel of LUGPA and Academic urologists and medical oncologists, which discussed key questions on the use of ADT in clinical practice – addressing questions that are not always answered by prior published guidelines. 

LUGPAs Actions During the COVID-19 Crisis - Protecting Independent Urology Practice
March 20, 2020 
It is critical that we hear about the magnitude of issues you are facing now with regard to the Coronavirus, so that we can communicate this growing list to the members of Congress. It’s imperative they understand exactly what is at stake. Read more here.

Telehealth Medicare Restrictions Relaxed Due to Coronavirus
March 19, 2020 
The Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074) was signed into law on March 6, 2020. It is a bipartisan bill that includes, among other provisions, waivers to certain telehealth requirements to allow Medicare patients to receive telehealth services at home.
Read more here.

LUGPA Postpones Events through April due to Coronavirus
March 2020 
NOTICE: Due to the Coronavirus Pandemic, LUGPA will postpone all LUGPA in-person events through April. These postponements include the Bladder Cancer Academy in Atlanta, the April Regional Meeting in Miami [now July 10-11] , the April Rising Chief Residents Summit in Miami [now July 10-11] and the April DC Fly-Ins. 
Read more here.

LUGPA announces new Resident Clinical Innovation Award 
March 2020 
The Resident Clinical Innovation Award recognizes and celebrates the innovative clinical work of urology residents and fellows that promotes and has the potential to enhance quality clinical outcomes. The award acknowledges the value of clinical innovation to harness new technologies, access to big data and/or the development of systems of care to prevent, diagnose or treat urological disease and promote urological health. Submit Now! 

LUGPA President Interviewed by Urology Times

LUGPA President Dr. Harris discusses legislative/policy challenges in 2020. Urology Times spoke with Dr. Harris at the 2019 LUGPA annual meeting in Chicago.

Members of Congress Need to Hear from You! 
LUGPA DC Fly-In Dates Announced for 2020

February 18, 2020 
Lawmakers are most responsive when they hear from physicians from their districts and states. That’s why we encourage your group to send a physician and/or senior administrator to Washington, DC to attend our Capitol Hill visits with the LUGPA Political Affairs Committee. 
Read more about the 2020 Fly-In dates.

LUGPA Supports Bipartisan House Bill: the PSA Screening for HIM Act
February 11, 2020 
On February 11, 2020, LUGPA sent a letter to House Representatives Bobby L. Rush and Larry Bucshon in strong support for H.R. 5200, the PSA Screening for High-risk Insured Men (HIM) Act. The letter states, The PSA Screening for HIM Act is critically important as the number of deaths due to prostate cancer has been increasing – prostate cancer is now the second highest cancer-related cause of death in the United States. Tragically, many of these lives would not have been lost had the cancer been detected early. The goal of your legislation is laudable as it will increase access to prostate cancer screenings by eliminating cost-sharing requirements to patients.   

LUGPA Escalates its Fight for Site-Neutral Payments
February 5, 2020 
Continuing our ongoing efforts as advocates for site-neutral payments, the LUGPA Board approved the development of an amicus curiae brief in support of the HHS Secretary’s action to cap rates for hospital clinic visit services in the off-campus outpatient department setting. To read more, click here.   

Report of the Advanced Prostate Cancer Consensus Conference 2019

January 28, 2020 
Innovations in treatments, imaging, and molecular characterization in advanced prostate cancer have improved outcomes, but there are still many aspects of management that lack high-level evidence to inform clinical practice. The Advanced Prostate Cancer Consensus Conference (APCCC) 2019 addressed some of these topics to supplement guidelines that are based on level 1 evidence.  To read more, click here.

Comment Letters Recently Submitted

January 1, 2020 
On December 31, 2019, LUGPA sent comment letters to the Department of Health and Human Services and the Centers for Medicare & Medicaid Services regarding 
the Anti-Kickback Statute Proposed Rule and the Stark Proposed Rule (respectively).  To read these letters and learn more about LUGPAs stance on these issues, click here .   

LUGPA 2019 Annual Meeting Recap
December 18, 2019
From start to finish of our three-day meeting, we saw the exchange of ideas, heard valuable insights and discussed solutions to enhance, improve and grow our individual groups. To see photos from the meeting and read a recap of all the meeting highlights, click here.

AUDIO Interview: Dr. Shore Discusses the article Preserving Independent Urology: LUGPA’s First Decade
December 18, 2019
Neal D. Shore, MD and E. David Crawford, MD, discuss the Reviews in Urology article (excerpted and linked below) and the ways in which LUGPA has advocated on behalf of community urology physicians and patients over the last ten years.

AACU, AUA, LUGPA Join Forces on ESWL Reimbursement
December 6, 2019
Representatives from the three national urology societies — AACU, AUA and LUGPA — met with the director and other staff from the Division of Outpatient Care at the Centers for Medicare & Medicaid Services (CMS) to urge the agency to reverse a coding change that will negatively impact urologists.

Preserving Independent Urology: LUGPA’s First Decade
December 2, 2019
Recently published in Reviews in Urology, this article is an encompassing overview of LUGPAs origins and evolution over the past ten years.

Private Equity Debated at LUGPA
November 2019
At the annual meeting of the Large Urology Group Practice Association (LUGPA) in Chicago, Illinois, Victor Houtz, MBA, CPA, the chief operating officer of New Jersey Urology, and E. Scot Davis, the CEO of Arkansas Urology, debated the pros and cons of partnering with private equity firms to fund physician practice groups. Houtz, whose organization joined with private equity firm J.W. Childs Associates in 2018, spoke in favor of it, while Davis took the opposing view.

Jeb Bush Discusses Politics and More at LUGPA

November 9, 2019 
A comprehensive rundown of Jeb Bushs keynote address and Q&A session at the 2019 LUGPA Annual Meeting was covered in Check it out here. More coverage of the 2019 LUGPA Annual Meeting can be found here.  

LUGPA Reappoints Three Members to Board of Directors
November 8, 2019
LUGPA announced today the reappointment of three members to the 2020 Board of Directors at the 2019 Annual Meeting held November 7-9 in Chicago.

E. Scot Davis is Elected to LUGPA Board of Directors
November 8, 2019
E. Scot Davis, CEO of Arkansas Urology, was elected to LUGPA’s Board of Directors at the 2019 Annual Meeting held on November 7-9 in Chicago. 

Urology Groups: 340B Program Reform Needed
October 18, 2019
A new study by the Partnership for Health Analytic Research (PHAR) appears to bolster arguments by independent physicians and those who operate outpatient clinics that they are at a substantial financial disadvantage against hospitals when it comes retaining profits from the administration of injectable and infused drugs. [...]

Profit Disparity Between Hospitals, Independent Practices Has Catastrophic Implications — 3 Thoughts from Dr. Mara Holton
October 2, 2019
Independent practices retained 9 percent of profits from physician-administered medicines, with hospitals retaining the other 91 percent, according to the Partnership for Health Analytic Researchs new Hospital Margin Analysis Report. Mara Holton, MD, discussed the findings with Beckers ASC Review. Dr. Holton is an independent physician and vice chair of the health policy committee for LUGPA, the Large Urology Group Practice Association. [...]

Overcoming Hurdles for Soon-To-Be Practitioners
The 2019 Rising Chief Resident Summit

September 26, 2019
In this video, Thomas F. Stringer, MD, FACS joins Neal Shore, MD to share highlights from his presentation at the 2019 Rising Chief Residents Summit. Dr. Stringer presented on crucial topics including vetting employment contracts, pursuing a career in academia, hospital-employed, industry employed, community, and independent practices. He also covered physician and practice agreements and what you dont know could hurt you, as well as resident training interests, future residency training, whats changed in part with resident training, the duty hour requirement, and business training.

Hospitals Retain 91% of Profit from Physician-Administered Drugs
September 17, 2019
Hospital keep a greater share of the gross profit margin on physician-administered drugs, indicating a need to level the playing field for physician practices, according to some experts. [...]

Hospitals Drive More Costs, Get Less Scrutiny
September 11, 2019
After a six-week recess (ahem, “district work period”), Congress is finally reconvening to commence work on drug-pricing legislation. A combination of populist ire over rising out-of-pocket drug costs and left-wing antipathy for for-profit healthcare has fueled legislation that would fundamentally rewrite the Medicare and Medicaid prescription drug programs. [...]

3 ASC Price Transparency Insights
September 10, 2019
Three ASC industry experts shared their insights on price transparency with Beckers ASC Review. [...]

How Benchmarking Helps Manage Your Time, Identify Problem Areas
August 22, 2019
LUGPA recently teamed with IntrinsiQ Specialty Solutions (IQSS), part of AmerisourceBergen, to support a new benchmarking program powered by InfoDive, IQSS’s business analytics solution. This collaboration, LUGPA says, will allow LUGPA member practices to compare independent group practice performance metrics against that of other member practices. [...]

How a 70-Physician Specialty Practice Centralized RCM Processes — 5 Insights 
August 07, 2019 

Maryanne Thompson is the controller for MidLantic Urology, a specialty practice with 46 locations and 70-plus physicians in the U.S. Ms. Thompson told Beckers ASC Review about MidLantic Urologys biggest revenue cycle management problem and how AI helped solve it. [...]

AAOS Will Be Closely Evaluating How Trumps Executive Order Affects Orthopedics 
July 17, 2019 
In late June, President Donald Trump issued an executive order intended to lower costs and help patients make informed decisions by increasing price transparency in healthcare. The decree elicited a cautiously optimistic response from the American Association of Orthopaedic Surgeons, which provides musculoskeletal education to more than 38,000 orthopedic surgeons around the world. [...]

CMS Proposed Rule on Bundled Payment for Radiation Therapy Services
July 16, 2019
On July 10th CMS released the proposed rule regarding the bundled payment for radiation therapy services. The development of a radiation oncology APM was stipulated in the payment freeze passed by Congress; for some time LUGPA has been engaged with CMS and other stakeholders to ensure that integrated urology practices were not excluded from participation. […]

New Study Shows Americans Are Concerned About How Hospital Mergers and Acquisitions Will Impact Their Care
December 7, 2018
CHICAGO, IL, December 3, 2018 – LUGPA, today released a new national survey of 1,191 adults that revealed more than sixty percent of adult Americans are concerned about the impact of hospital mergers and acquisitions on their access to affordable care, with 25 percent reporting that this increasing trend is a threat to their health. […]

LUGPA to Testify at Stark Law Hearing in Support of Modernization
July 17, 2018
WASHINGTON, DC, July 17, 2018 – Appearing today at a hearing of the United States House of Representatives’ Ways and Means Committee entitled, “Modernizing Stark Law to Ensure the Successful Transition from Volume to Value in the Medicare Program,” LUGPA’s Past President and Advanced Payment Model Task Force Chair, Gary Kirsh, MD, testified on the […]

LUGPA Supports CMS’ Efforts to Modernize Stark Law
June 22, 2018
On June 20, 2018, The Centers for Medicare & Medicaid Services (CMS) issued a request for public comment on how to address the regulatory impact and burden of the physician self-referral law known as Stark Law. LUGPA issued the following statement. LUGPA commends CMS for its efforts to address the barriers created by outdated Stark […]

LUGPA statement on UPSPTF Recommendations
May 9, 2018
On May 8, the United States Preventive Services Task Force (USPSTF) posted its Prostate Cancer Screening final recommendations. LUGPA recognizes the decision by USPSTF to finalize its preliminary Grade “C” recommendation for PSA screening of men aged 55-69 is an improvement over its 2012 one-size-fits-all recommendation against PSA-based screening for any man. Yet, our […]

Proposed Certificate of Need Effort in Michigan Defeated
March 29, 2018
Urologists Mobilized to Defeat Threat to Independent Practices Chicago, IL, March 27, 2018 – In the wake of a successful coordinated effort by LUGPA and its Michigan-based member practices and in conjunction with other health care providers to defeat a proposed Certificate of Need requirement for […]

LUGPA Endorses AACU Policy Statement on Genomic Testing
March 12, 2018
Chicago, March 7, 2018—The National Comprehensive Cancer Network (NCCN) guidelines for Prostate Cancer version 1.2018, incorporate a position statement on genomic testing in prostate cancer. The position statement was proposed by the American Association of Clinical Urologists (AACU) and endorsed by LUGPA. The following statement can be […]

Budget Proposal Focuses Discussion of Physician Self-Referral Reform
February 19, 2018
New Budget Encourages Participation in APMs Chicago, IL, February 16, 2018 – Earlier this week, President Trump released a proposed budget for 2019, which included several proposals that impact independent physician practices. Two of the outlined proposals will directly impact LUGPA practices: the first proposal eliminates the […]

Healthcare Funding Addressed in Congressional Budget Resolution
February 9, 2018
LUGPA Sees Opportunity for Independent Practices Under New Healthcare Policies Chicago, IL, February 9, 2018 – Today, the United States Congress passed a major budget resolution to fund the government, which included several provisions important to health care providers. LUGPA has been a vocal champion for […]

LUGPA Supports Government’s Efforts to Modernize Stark Law
January 25, 2018
LUGPA Supports Government’s Efforts to Modernize Stark Law New Task Force Announced by Federal Government Recognizes a Glaring Need Chicago, IL, January 22, 2018–On January 17, 2018, CMS Administrator Seema Verma announced that The Centers for Medicare & Medicaid Services (CMS) will form an interagency group to review the regulatory barriers posed by Stark law. […]